Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2012

Open Access 01-06-2012 | Poster presentation

P01.36. Assessment of commercial formulations of mucuna pruriens seeds for Levodopa (L-DOPA) content

Authors: A Soumyanath, T Denne, A Peterson, L Shinto

Published in: BMC Complementary Medicine and Therapies | Special Issue 1/2012

Login to get access

Excerpt

Mucuna pruriens (mucuna) seeds contain 3-6% L-DOPA, and have been used in traditional Ayurvedic medicine to treat diseases resembling Parkinson’s disease (PD). Pilot studies in PD show that mucuna seed powder has similar effects to conventional levodopa/carbidopa medication. Formulations of mucuna seed are readily available through the internet, and are used by some PD patients as an alternative to conventional levadopa/carbidopa medication. The purpose of this study was to examine the L-DOPA content of a range of popular mucuna products in order to assess the veracity of label claims. …
Metadata
Title
P01.36. Assessment of commercial formulations of mucuna pruriens seeds for Levodopa (L-DOPA) content
Authors
A Soumyanath
T Denne
A Peterson
L Shinto
Publication date
01-06-2012
Publisher
BioMed Central
DOI
https://doi.org/10.1186/1472-6882-12-S1-P36

Other articles of this Special Issue 1/2012

BMC Complementary Medicine and Therapies 1/2012 Go to the issue